| Literature DB >> 1553942 |
V Jochem1, R Kirkpatrick, J Greenson, M Brogan, T Sturgis, C Cook-Glenn.
Abstract
Omeprazole is a new hydrogen-potassium adenosine triphosphatase antagonist with indications for severe reflux esophagitis and Zollinger-Ellison syndrome. Side effects involving the liver have consisted of minimal elevations of hepatocellular enzymes with higher dosages. We present what we believe is the first reported case of fulminant hepatic failure related to omeprazole.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1553942
Source DB: PubMed Journal: Am J Gastroenterol ISSN： 0002-9270 Impact factor: 10.864